Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Qiangqiang Dai
Observed name:
Q. Dai
Institution:
Chengdu University of Traditional Chinese Medicine
Observed institutions:
Sun Yat-sen University,
University of Kansas Medical Center,
The First Affiliated Hospital, Sun Yat-sen University,
Chengdu University of Traditional Chinese Medicine
ORCID:
0009-0009-3977-1738
Observed ORCID:
0009-0009-3977-1738
OpenAlex ID:
A5102998238
Therapeutic potential of mesenchymal stem cell-derived extracellular vesicle in nonalcoholic fatty liver disease: a systematic review and meta-analysis of preclinical evidence
2025
·
Qiangqiang Dai
, Di Zhu
, et al.
·
Lipids in Health and Disease
·
9
PDF
P2.10A.05 Ipat-Lung: A Multi-Center Phase 2 Study of Ipatasertib Plus Docetaxel in NSCLC Patients who Have Failed or Are Intolerant to 1st Line Immunotherapy
2024
·
J. Zhang
, C.H. Huang
, et al.
·
Journal of Thoracic Oncology
·
2
PDF
98P Camrelizumab as neoadjuvant, first- or later-line treatment for non-small cell lung cancer (NSCLC): A retrospective real-world study (CTONG2004)
2021
·
C. Xu
, Q. Chen
, et al.
·
Annals of Oncology
·
2
Cumulative temporal association between assisted reproductive technology and childhood cancer: a systematic review and meta-analysis of observational studies
2025
·
Yanjie Jiang
, Qiangqiang Dai
, et al.
·
Frontiers in Oncology
·
1
PDF
Show more works
View as search
Works count:
4
Citation count:
14
H-index:
2
I10-index:
Year
Topic
Type